Covered recipient · General Payments record
HARIS ZAHOOR
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$12,007.40
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $139.02 | 7 |
| Education | $38.09 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $48.93 | 2 |
| Celgene Corporation | $35.36 | 2 |
| PFIZER INC. | $21.29 | 1 |
| AVEO Pharmaceuticals, Inc. | $20.00 | 1 |
| Merck Sharp & Dohme Corporation | $18.09 | 1 |
| JAZZ PHARMACEUTICALS INC. | $17.47 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aveo Pharmaceuticals, Inc. | $20.00 | 10/11/2024 | Education | Undisputed | 01/23/2026 | 1143478312 | CMS |
| Celgene Corporation | $14.04 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101102044 | CMS |
| Celgene Corporation | $21.32 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101102046 | CMS |
| Eisai Inc. | $21.78 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110748064 | CMS |
| Eisai Inc. | $27.15 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110748062 | CMS |
| JAZZ PHARMACEUTICALS INC. | $17.47 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150228235 | CMS |
| Merck Sharp & Dohme LLC | $18.09 | 11/05/2024 | Education | Undisputed | 01/23/2026 | 1141799966 | CMS |
| Novartis Pharmaceuticals Corporation | $15.97 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087439218 | CMS |
| PFIZER INC. | $21.29 | 06/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131338070 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.